Reprogrammed Stomach Tissue as a Renewable Source of Functional β Cells for Blood Glucose Regulation

Cell Stem Cell
Chaiyaboot AriyachetQiao Zhou

Abstract

The gastrointestinal (GI) epithelium is a highly regenerative tissue with the potential to provide a renewable source of insulin(+) cells after undergoing cellular reprogramming. Here, we show that cells of the antral stomach have a previously unappreciated propensity for conversion into functional insulin-secreting cells. Native antral endocrine cells share a surprising degree of transcriptional similarity with pancreatic β cells, and expression of β cell reprogramming factors in vivo converts antral cells efficiently into insulin(+) cells with close molecular and functional similarity to β cells. Induced GI insulin(+) cells can suppress hyperglycemia in a diabetic mouse model for at least 6 months and regenerate rapidly after ablation. Reprogramming of antral stomach cells assembled into bioengineered mini-organs in vitro yielded transplantable units that also suppressed hyperglycemia in diabetic mice, highlighting the potential for development of engineered stomach tissues as a renewable source of functional β cells for glycemic control.

References

Dec 28, 2002·Diabetes·Alexandra E ButlerPeter C Butler
Mar 27, 2004·Endocrinology·Susan E SchonhoffAndrew B Leiter
Jul 15, 2004·Transplantation Proceedings·T MaemuraJ P Vacanti
Dec 2, 2008·Cell Metabolism·Frank ReimannFiona M Gribble
Dec 20, 2008·Science·J B Gurdon, D A Melton
Apr 24, 2009·Developmental Cell·Nan GaoKlaus H Kaestner
Dec 23, 2009·Molecular and Cellular Endocrinology·Catherine Lee May, Klaus H Kaestner
Apr 13, 2010·Expert Review of Clinical Immunology·Jamil AzziReza Abdi
Jun 30, 2010·Nature Reviews. Endocrinology·Benjamin C T FieldStephen R Bloom
May 17, 2011·The Journal of Surgical Research·Allison L SpeerTracy C Grikscheit
Mar 13, 2012·Nature Genetics·Chutima TalchaiDomenico Accili
Jun 8, 2012·Cold Spring Harbor Perspectives in Medicine·Matthias Hebrok
Jul 4, 2012·Seminars in Cell & Developmental Biology·Maria Cristina Nostro, Gordon Keller
Nov 7, 2012·Molecular and Cellular Biology·Michael P VerziRamesh A Shivdasani
Mar 13, 2014·Annals of the New York Academy of Sciences·Jacqueline V Schiesser, James M Wells
Jul 1, 2014·Nature Communications·Ryotaro BouchiDomenico Accili
Dec 17, 2014·Nature Communications·Salvatore SimminiJacqueline Deschamps
Mar 4, 2015·The EMBO Journal·Bjarki JohannessonDieter Egli
Mar 19, 2015·Diabetes·Shivatra Chutima Talchai, Domenico Accili

❮ Previous
Next ❯

Citations

Mar 5, 2016·Cell Stem Cell·Heather A McCauley, James M Wells
Sep 10, 2016·Cell·Deepak Srivastava, Natalie DeWitt
Sep 13, 2016·Diabetes, Obesity & Metabolism·W StaelsH Heimberg
Sep 13, 2016·Diabetes, Obesity & Metabolism·C HonoréO D Madsen
Sep 13, 2016·Diabetes, Obesity & Metabolism·J Shirakawa, R N Kulkarni
Oct 4, 2016·The Journal of Clinical Investigation·Jacqueline R BenthuysenMaike Sander
Jan 19, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Chaoxing YangCraig Dorrell
Oct 7, 2017·Pediatric Research·Oren PleniceanuBenjamin Dekel
Nov 22, 2018·The Journal of Biological Chemistry·Abdelfattah El OuaamariTerry G Unterman
Aug 16, 2017·Nature Reviews. Gastroenterology & Hepatology·Cara EllisTimothy J Kieffer
May 11, 2019·Journal of Biological Engineering·C P Healy, T L Deans
Nov 27, 2019·Cold Spring Harbor Perspectives in Biology·Silvia RuzittuFrancesca M Spagnoli
Apr 16, 2019·Regenerative Engineering and Translational Medicine·Lauren N RandolphXiaojun Lance Lian
Mar 28, 2019·Current Molecular Medicine·Jin Zhou, Jie Sun
Jun 27, 2020·Nature Reviews. Endocrinology·Gopika G NairMatthias Hebrok
May 10, 2018·Bioscience Reports·Yukimasa TakedaPing Dai
Jul 25, 2018·Nature Cell Biology·Ramesh A Shivdasani
May 18, 2018·Nature·Qiao Zhou, Douglas A Melton
Jan 16, 2020·World Journal of Diabetes·Adebola Matthew GiwaAbdel Rahim A Hamad
Jun 27, 2020·World Journal of Gastroenterology : WJG·Irina V ArutyunyanGennady T Sukhikh
Nov 1, 2016·Science China. Life Sciences·Jiaqi LuQiao Zhou
Aug 17, 2017·PloS One·Feorillo GalivoMarkus Grompe
Jun 3, 2018·Nature Reviews. Molecular Cell Biology·Mingqi Xie, Martin Fussenegger
Jun 13, 2019·Journal of the Endocrine Society·Wendy M McKimpson, Domenico Accili
Dec 23, 2016·Nature Reviews. Drug Discovery·Tejal Desai, Lonnie D Shea
Sep 9, 2017·Transplantation·Christian SchuetzUNKNOWN IPITA YIC Young Investigator Committee
Feb 19, 2017·Protein & Cell·Xiaojie MaSaiyong Zhu
Aug 31, 2019·Stem Cells International·Yoojin SeoHyung-Sik Kim
Jul 25, 2019·Annual Review of Cell and Developmental Biology·Begüm Aydin, Esteban O Mazzoni
Jun 10, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Moritz Mall, Marius Wernig
Nov 14, 2017·Expert Opinion on Biological Therapy·Shengli Dong, Hongju Wu
Sep 11, 2019·Molecular Metabolism·Daniela NasteskaDavid J Hodson
Nov 11, 2019·Emerging Topics in Life Sciences·Adam M VogelTara L Deans
Jan 31, 2021·Nature Communications·Daniela NasteskaDavid J Hodson
May 18, 2021·Frontiers in Cell and Developmental Biology·Wojciech J SzlachcicMalgorzata Borowiak
Jun 2, 2021·Current Opinion in Genetics & Development·Abigail Isaacson, Francesca M Spagnoli
Dec 10, 2021·Biochemical Society Transactions·Mohamed SalehKrishna Prasadan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Brain Organoids in Disease Modeling

Brain organoids are three-dimensional cell culture models derived from human pluripotent stem cells. Since they resemble the embryonic brain, they can be used to help study brain biology, early brain development, and brain diseases. Discover the latest research on brain organoids in disease modeling here.

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.